These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3740545)

  • 1. Continuous infusion treatment with pentoxifylline in patients with severe peripheral vascular occlusive disease.
    Angelides NS
    Angiology; 1986 Aug; 37(8):555-64. PubMed ID: 3740545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
    Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
    Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
    Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
    Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
    Schweiger H; Ortmeier CJ
    Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B; Doppelfeld E
    Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group.
    Lindgärde F; Jelnes R; Björkman H; Adielsson G; Kjellström T; Palmquist I; Stavenow L
    Circulation; 1989 Dec; 80(6):1549-56. PubMed ID: 2688972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
    Ehrly AM; Saeger-Lorenz K
    Angiology; 1987 Feb; 38(2 Pt 1):93-100. PubMed ID: 3548493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of pentoxifylline for end-stage peripheral vascular disease.
    Loyd RG; Prian GW; Gomez H; Laub J; Mertz GH
    Angiology; 1987 Apr; 38(4):304-8. PubMed ID: 3578918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral pentoxifylline therapy on venous lower extremity ulcers due to deep venous incompetence.
    Angelides NS; Weil von der Ahe CA
    Angiology; 1989 Aug; 40(8):752-63. PubMed ID: 2604770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease.
    Sternitzky R; Seige K
    Curr Med Res Opin; 1985; 9(9):602-10. PubMed ID: 4053674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)].
    Rudofsky G; Brock FE; Ulrich M; Nobbe F
    Med Klin; 1979 Jul; 74(28-29):1093-6. PubMed ID: 556192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
    Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
    Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
    von Westphalen JG
    MMW Munch Med Wochenschr; 1977 Jul; 119(26):901-4. PubMed ID: 408616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
    Crowder JE; Cohn JB; Savitsky JP; Morgan DL; Slywka J; Cobert BL; Hryniewicki SW; Piccirillo RT; Wilcox CS
    Angiology; 1989 Sep; 40(9):795-802. PubMed ID: 2669564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of arterial diseases. A study with Trental 400].
    Tannenberg G
    Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.